Home page Home page

Zolvix
monepantel


PACKAGE LEAFLET:

ZOLVIX 25 mg/ml oral solution for sheep


  1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT


    Marketing authorisation holder: Elanco GmbH

    Heinz-Lohmann-Str. 4

    27472 Cuxhaven Germany


    Manufacturer responsible for batch release: Elanco France S.A.S

    26 Rue de la Chapelle F-68330 Huningue France


  2. NAME OF THE VETERINARY MEDICINAL PRODUCT


    ZOLVIX 25 mg/ml oral solution for sheep Monepantel


  3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS

    Each ml of ZOLVIX orange clear oral solution contains 25 mg of monepantel Other ingredients:

    RRR-α-tocopherol

    Beta-carotene Maize oil Propylene glycol

    Macrogolglycerol hydroxystearate Polysorbate 80

    Propylene glycol monocaprylate Propylene glycol dicaprylocaprate

  4. INDICATION(S)


    ZOLVIX oral solution is a broad spectrum anthelmintic for the treatment and control of gastro- intestinal nematode infections and associated diseases in sheep including lambs, hoggets, breeding rams and ewes.

    image

    Spectrum of activity includes fourth larvae and adults of:


    Haemonchus contortus* Teladorsagia circumcincta*

    T. trifurcata*

    T. davtiani* Trichostrongylus axei*

    T. colubriformis

    T. vitrinus Cooperia curticei

    C. oncophora Nematodirus battus

    N. filicollis

    N. spathiger Chabertia ovina

    Oesophagostomum venulosum


    *Including inhibited larvae


  5. CONTRAINDICATIONS


    None.


  6. ADVERSE REACTIONS


    None known.

    If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.


  7. TARGET SPECIES


    Sheep

  8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION


    Dose table


    Bodyweight, kg

    Dose, ml

    10 – 15

    1.5

    16 – 20

    2

    21 – 25

    2.5

    26 – 30

    3

    31 – 35

    3.5

    36 – 40

    4

    41 – 50

    5

    51 – 60

    6

    61 – 70

    7

    > 70 kg

    1 ml for each additional 10 kg


    Administer orally with a suitable dose device.


  9. ADVICE ON CORRECT ADMINISTRATION


    The dose rate is 2.5 mg/kg bodyweight of monepantel.

    The veterinary medicinal product is administered as a single treatment. However, the administration may be repeated, depending on the epidemiological situation in different areas.

    To ensure administration of a correct dose, bodyweight should be determined as accurately as possible. Accuracy and proper functioning of the dose device should be checked.


    If animals are to be treated collectively rather than individually, they should be grouped according to their bodyweight and dosed according to the heaviest animal within the group, in order to avoid underdosage.

    To assure complete swallowing of this low volume solution, administer orally on the back of the tongue. Drenching equipment should be cleaned after use.


  10. WITHDRAWAL PERIOD(S)


    7 days.

    Not authorised for use in animals producing milk for human consumption.


  11. SPECIAL STORAGE PRECAUTIONS


    Keep out of the sight and reach of children.


    Do not use this veterinary medicinal product after the expiry date which is stated on the label. Shelf life after first opening the container: 1 year.

  12. SPECIAL WARNING(S)


    Special warnings for each target species:

    The efficacy has not been established in sheep weighing less than 10 kg.

    Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:

    • Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. It is recommended that product is used not more than twice in one year.

    • Underdosage, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dose device.

      In order to help delay the development of resistance, users are advised to check the success of the treatment (e.g. clinical appearance, faecal egg counts). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Tests) in discussion with their animal health advisor. Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and

      having a different mode of action should be used.


      Increasing refugia (i.e. a source of parasites which have not been exposed to the anthelmintic) has been demonstrated to delay the development of resistance. However, this should be considered only after advice has been taken from an animal health advisor.


      Special precautions for use in animals:

      The safety has not been established in sheep weighing less than 10 kg or under 2 weeks of age.


      Special precautions to be taken by the person administering the veterinary medicinal product to animals:

      Personal protective equipment consisting of gloves should be worn when handling the veterinary medicinal product. In case of accidental spillage onto skin or into eyes, wash immediately with water. Take off any contaminated clothes. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

      Do not eat, drink or smoke whilst handling the veterinary medicinal product. Wash hands and exposed skin after handling the veterinary medicinal product.


      Pregnancy and lactation:

      Can be used in breeding sheep including pregnant and lactating ewes.


      Interaction with other medicinal products and other forms of interaction:

      No interaction with other medicinal products and other forms of interaction are known.


      Overdose (symptoms, emergency procedures, antidotes): No adverse effects were observed after a 10-fold overdose.


      Incompatibilities:

      In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.


  13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY


    Medicines should not be disposed of via wastewater or household waste.

    Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.

  14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED


    /.


  15. OTHER INFORMATION


Monepantel is an anthelmintic belonging to the amino-acetonitrile derivative (AAD) class of molecules.


ZOLVIX was shown to be effective against strains of gastro-intestinal parasites, listed in section 4, resistant to (pro)benzimidazoles, levamisole, morantel, macrocyclic lactones and H. contortus strains resistant to salicylanilides. In addition, the product was shown to be effective against 4th stage larvae of a strain of H. contortus in a laboratory study where a combination of abamectin with derquantel was not effective.

Isolated cases of resistance against monepantel have been identified within the European Union. Pack sizes of 250 ml, 500 ml, 1 l, 2.5 l, and 5 l

Not all pack sizes may be marketed.


For any information about this veterinary medicinal product, please contact the marketing authorisation holder.